» Articles » PMID: 31175577

Alterations in Atrial Ion Channels and Tissue Structure Promote Atrial Fibrillation in Hypothyroid Rats

Overview
Journal Endocrine
Specialty Endocrinology
Date 2019 Jun 9
PMID 31175577
Citations 9
Authors
Affiliations
Soon will be listed here.
Abstract

Purpose: It is well known that hyperthyroidism is associated with atrial fibrillation (AF); however, the relationship between hypothyroidism and AF remains controversial.

Methods: Hypothyroidism was established in rats by two methods: methimazole-induced (MMI) and thyroidectomy (TX). MMI model includes control (n = 10), MMI (n = 10), and MMI + L-thyroxine (T4, n = 10). Methimazole was given intragastrically in MMI and MMI + T4 for 12 weeks, and T4 was added intragastrically in MMI + T4 at week 5. TX model includes sham (n = 10), TX (n = 10), and TX + T4 (n = 10). Four weeks after surgery, rats in TX + T4 received T4 for 8 weeks. Triiodothyronine (T3), T4, and thyroid-stimulating hormone (TSH) were measured. Electrophysiology, tissue structure and function, and protein levels of potassium and L-type calcium channels were assessed in the atria.

Results: Severe changes in the atrial structure of hypothyroid rats were observed. Compared with euthyroid rats, atrial effective refractory period (AERP) in hypothyroid rats was significantly shortened; accordingly, inducibility and duration of AF were considerably increased. Protein levels of minK, Kv1.5, Kv4.2, Kv4.3, Kv7.1, and Cav1.2 were upregulated in hypothyroid rats, whereas there was only a tendency toward increased Kir2.1. Kv11.1 was statistically upregulated in the MMI model and had an increasing tendency in the TX model. Conversely, Kir3.1 and Kir3.4 were downregulated in hypothyroid rats. The above changes could be partially inhibited by T4 treatment.

Conclusions: AERP shortening due to altered protein levels of ion channels and atrial structural changes increased the susceptibility to AF in hypothyroidism. Thyroid replacement therapy could prevent electrical and structural remodeling under hypothyroid condition.

Citing Articles

The common pathogenesis of nodular goiter in both sexes: An exploration into gene expression and signaling pathways.

Gao X, Gao J, Sun Y, Zhao J, Geng L, Wang C Heliyon. 2024; 10(13):e33411.

PMID: 39035545 PMC: 11259846. DOI: 10.1016/j.heliyon.2024.e33411.


[Arrhythmias in thyroid dysfunction].

Brenner R, Bilz S, Busch S, Rickli H, Ammann P, Maeder M Herzschrittmacherther Elektrophysiol. 2024; 35(3):183-192.

PMID: 39023744 DOI: 10.1007/s00399-024-01030-0.


Reversible acute heart failure induced by thyrotoxic cardiomyopathy: A case report.

Shi R, Meng W, Yin J, Xue W, Deng Y Medicine (Baltimore). 2024; 103(21):e38305.

PMID: 38788008 PMC: 11124643. DOI: 10.1097/MD.0000000000038305.


Low-normal free triiodothyronine as a predictor of post-operative atrial fibrillation after surgical coronary revascularization.

Hua C, Liu P, Zhang M, Niu J, Wang L, Zhong G J Thorac Dis. 2024; 16(2):1191-1200.

PMID: 38505029 PMC: 10944733. DOI: 10.21037/jtd-23-1646.


Association Between Pre-Radiofrequency Catheter Ablation Serum Lipid Levels and Recurrence of Atrial Fibrillation in 412 Patients in Beijing, China: A Single-Center Study.

Li Z, Liu T, Huang Q, Liu X, Song Y, Guo X Med Sci Monit. 2023; 29:e938288.

PMID: 36733233 PMC: 9904332. DOI: 10.12659/MSM.938288.


References
1.
Worku B, Tortolani A, Gulkarov I, Isom O, Klein I . Preoperative hypothyroidism is a risk factor for postoperative atrial fibrillation in cardiac surgical patients. J Card Surg. 2015; 30(4):307-12. DOI: 10.1111/jocs.12513. View

2.
Ma M, Watanabe K, Watanabe H, Hosaka Y, Komura S, Aizawa Y . Different gene expression of potassium channels by thyroid hormone and an antithyroid drug between the atrium and ventricle of rats. Jpn Heart J. 2003; 44(1):101-10. DOI: 10.1536/jhj.44.101. View

3.
Zhang Y, Dedkov E, Lee 3rd B, Li Y, Pun K, Gerdes A . Thyroid hormone replacement therapy attenuates atrial remodeling and reduces atrial fibrillation inducibility in a rat myocardial infarction-heart failure model. J Card Fail. 2014; 20(12):1012-9. PMC: 4250313. DOI: 10.1016/j.cardfail.2014.10.003. View

4.
Klein I, Danzi S . Thyroid Disease and the Heart. Curr Probl Cardiol. 2016; 41(2):65-92. DOI: 10.1016/j.cpcardiol.2015.04.002. View

5.
Schmitt N, Grunnet M, Olesen S . Cardiac potassium channel subtypes: new roles in repolarization and arrhythmia. Physiol Rev. 2014; 94(2):609-53. DOI: 10.1152/physrev.00022.2013. View